Showing 1221-1230 of 3009 results for "".
An Unusual Case of Descending Paralysis Caused by West Nile Virus
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/an-unusual-case-of-descending-paralysis-caused-by-west-nile-virus/30523/Clinicians should consider a diagnosis of West Nile Virus in patients with acute flaccid paralysis, particularly those who come from areas where WNV is endemic.Disparities in Alzheimer Disease and Alzheimer-Related Dementias: Considerations for Clinical Decision-Making and Treatment
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/disparities-in-alzheimer-disease-and-alzheimer-related-dementias-considerations-for-clinical-decision-making-and-treatment/32016/Taking into account social determinants of health and identifying solutions to improve patient care.Pharmacologic Management of Behavioral Challenges and Psychiatric Comorbidities in People With Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pharmacologic-management-of-behavioral-challenges-and-psychiatric-comorbidities-in-people-with-epilepsy/39969/Treatment of behavioral and psychiatric comorbidities in people with epilepsy requires careful consideration of underlying causes, symptom profile, antiseizure medications, and epilepsy type.Headache Medicine Update: What’s New in CGRP Functional Blocking Agents
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-medicine-update-whats-new-in-cgrp-functional-blocking-agents/32126/CGRP blocking agents have demonstrated success in migraine treatment and can be used in various settings, in different combinations, and for different headache conditions.Updates in Bruton Tyrosine Kinase Inhibition for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/updates-in-bruton-tyrosine-kinase-inhibition-for-multiple-sclerosis/31975/Ongoing clinical trials will elucidate potential advantages and safety of these novel medications for future treatment of multiple sclerosis.Neurologic Manifestations & Associations of COVID-19
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neurologic-manifestations-associations-of-covid-19/31739/High-quality epidemiologic data is still urgently needed to better understand neurologic effects of COVID-19.Point/Counterpoint: Neurofilament Light
https://practicalneurology.com/diseases-diagnoses/imaging-testing/pointcounterpoint-neurofilament-light/31628/Ready for prime time as a biomarker for multiple sclerosis or not?Relapse Management in Multiple Sclerosis: Corticosteroids Remain the Linchpin of Therapies
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/relapse-management-in-multiple-sclerosis-corticosteroids-remain-the-linchpin-of-therapies/32084/Several modalities are available for the treatment of multiple sclerosis relapse, including corticosteroids, intravenous immunoglobulins, and therapeutic apheresis.Diagnostic Considerations for New-Onset Epilepsy in Older Adults
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/diagnostic-considerations-for-new-onset-epilepsy-in-older-adults/32175/Early recognition and accurate diagnosis by health care providers are key to the optimal management of the older adult with epilepsy.Neurologic Complications of Tick-Borne Diseases
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neurologic-complications-of-tick-borne-diseases/32152/As the incidence of tick-borne diseases increases, neurologists must recognize and treat their neurologic manifestations.